Efficacy and safety of Anas barbariae 200K in influenza-like illness: a randomized double-blind,…

Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study
Fengxia Xue, Jialin Li, Siyuan Hu +11
Pharmaceutical Biology27 Oct 2026Peer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMC
Comparative evaluation of the antipyretic and analgesic efficacy and safety of a fast-release paracetamol 650 mg formulation vs. conventional paracetamol formulations in adults with acute febrile or febrile-pain conditions: a multicenter randomized controlled trial
Susobhan Mondal, S. K. Ashik Ikbal, Sumit Agrawal +11
Frontiers in pain research (Lausanne, Switzerland)16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Efficacy and safety of sivelestat sodium hydrate adjunct to remifentanil for analgesia in patients under mechanical ventilation (SIDING trial): protocol of a multicenter, randomized, double-blinded, placebo-controlled trial
Zongwen Zhang, Peng Wang, Bin Yao +20
Frontiers in medicine16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trial
Michihiro Iwaki, Hiroshi Tobita, Yuya Seko +38
eClinicalMedicine1 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
A multicenter randomized controlled study to evaluate the efficacy of an artificial intelligence–based electrocardiography for the detection of atrial fibrillation in patients with suspected symptoms (DEEP-AF)
Ki-Jeung Lee, Chang-Ok Seo, Joo Hee Jeong +29
Heart rhythm O220 Jul 2026Peer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC

Cite

BibTeX

@misc{gupta2026efficacy,
  title = {{Efficacy and safety of Anas barbariae 200K in influenza-like illness: a randomized double-blind, placebo-controlled, multicenter study}},
  author = {M. GUPTA and A. TAJNE and P. CHAVAN and I. CHANEL and S. CHANUT and N. BOUJEDAINI and M. GUPTA},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.01.26361819},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.01.26361819v1},
}

RIS

TY  - UNPB
TI  - Efficacy and safety of Anas barbariae 200K in influenza-like illness: a randomized double-blind, placebo-controlled, multicenter study
AU  - M. GUPTA
AU  - A. TAJNE
AU  - P. CHAVAN
AU  - I. CHANEL
AU  - S. CHANUT
AU  - N. BOUJEDAINI
AU  - M. GUPTA
PY  - 2026
DA  - 2026/09/01
PB  - medRxiv
DO  - 10.64898/2026.09.01.26361819
UR  - https://www.medrxiv.org/content/10.64898/2026.09.01.26361819v1
ER  -

Related

Cite